Ravata Solutions Revenue and Competitors
Estimated Revenue & Valuation
- Ravata Solutions's estimated annual revenue is currently $1.6M per year.
- Ravata Solutions's estimated revenue per employee is $155,000
Employee Data
- Ravata Solutions has 10 Employees.
- Ravata Solutions grew their employee count by -17% last year.
Ravata Solutions Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Ravata Solutions?
Ravata Solutions is a fertility and reproduction start up specializing in hardware and diagnostics to transform the IVF laboratory with automated assisted reproductive technologies (AART). The flagship device improves human disease model development used in pre-clinical studies with implications in improving drug efficacy, medical genetics research, and single zygote CRISPR applications. Their upcoming product line for IVF clinicians and embryo transfer specialists will assist in identifying the healthiest embryo for improved pregnancy rates. For all requests for more information on our technology please reach out to: contact@ravatasolutions.com Stay connected with our team by following us on LinkedIn, Twitter, and Facebook! Twitter: @RavataSolutions Fb: RavataSolutions
keywords:N/A
N/A
Total Funding
10
Number of Employees
$1.6M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in Davis
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $1M | 11 | N/A | N/A |
#2 | $1.7M | 13 | -24% | N/A |
#3 | $1.2M | 14 | 17% | N/A |
#4 | $2.3M | 15 | -17% | N/A |
#5 | N/A | 16 | -11% | N/A |